Spinal Muscular Atrophy Market– A Genetic Disorder Affecting Part of the Nervous System

Spinal muscular atrophy (SMA) is a genetic disorder that affects the control of muscle movement. It is caused due to loss of specialized nerve cells, called motor neurons, in the spinal cord and brainstem. The loss of motor neurons leads to weakness and atrophy of muscles used for activities such as sitting up, walking, crawling, and controlling head movement. In severe cases, the ... Read more

Spinal muscular atrophy (SMA) is a genetic neuromuscular disease that attacks the motor neurons associated with muscles used for activities like crawling, walking, head and neck control, and swallowing. Gene therapy is emerging as a promising approach to treat SMA by delivering a functional copy of the SMN1 gene to produce more SMN protein.

The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 2089.13 Bn in 2024 and is expected to exhibit a ... Read more